Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 21;23(6):3394.
doi: 10.3390/ijms23063394.

SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro

Affiliations

SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro

Zhengcun Wu et al. Int J Mol Sci. .

Abstract

Growing cases of patients reported have shown a potential relationship between (severe acute respiratory syndrome coronavirus 2) SARS-CoV-2 infection and Parkinson's disease (PD). However, it is unclear whether there is a molecular link between these two diseases. Alpha-synuclein (α-Syn), an aggregation-prone protein, is considered a crucial factor in PD pathology. In this study, bioinformatics analysis confirmed favorable binding affinity between α-Syn and SARS-CoV-2 spike (S) protein and nucleocapsid (N) protein, and direct interactions were further verified in HEK293 cells. The expression of α-Syn was upregulated and its aggregation was accelerated by S protein and N protein. It was noticed that SARS-CoV-2 proteins caused Lewy-like pathology in the presence of α-Syn overexpression. By confirming that SARS-CoV-2 proteins directly interact with α-Syn, our study offered new insights into the mechanism underlying the development of PD on the background of COVID-19.

Keywords: Parkinson’s disease; SARS-CoV-2; alpha-synuclein; nucleocapsid protein; spike protein.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
SARS-CoV-2 proteins’ interaction with α-Syn by protein–protein docking. (A) The protein–protein docking result of S_RBD (PDB ID: 1XQ8) and α-Syn. (A-1) Docking model showing the interaction of S_RBD (brown) and α-Syn (yellow). (A-2) Detail of the interacting residue of S_RBD and α-Syn. (A-3) Pie chart shows the key interaction of residues between S_RBD and α-Syn. (B) The protein–protein docking result of N_CTD (PDB ID: 6WJI) and α-Syn. (B-1) Surface diagram of N_CTD (brow) and α-Syn (yellow) complex model. (B-2) Detail of an interacting residue of N_CTD and α-Syn. (B-3) Pie chart shows the key interaction of residues between N_CTD and α-Syn. (C) The protein–protein docking result of N_NTD (PDB ID: 6VYO) and α-Syn. (C-1) Docking model of interaction of N_NTD and α-Syn. (C-2) Detail of an interacting residue of N_NTD and α-Syn. (C-3) Pie chart shows the key interaction of residues between N_NTD and α-Syn. Key interactions between residues are presented as dotted lines. The key interactions are color coded as follows: salt bridge (red), disulfide bonds (yellow), hydrogen bonds (blue), and non-bonded contacts (orange). The number of lines indicates the potential number of bonds. For non-bonded contacts, the width of the striped line indicates the number of potential contacts.
Figure 2
Figure 2
α-Syn directly interacts with SARS-CoV-2 proteins in HEK293 cells. (A) The distribution and location of SARS-CoV-2 proteins and α-Syn in HEK293 cells, as analyzed by confocal microscopy. DAPI was used to stain nuclei. (B) Interaction between endogenous SARS-CoV-2 S protein and α-Syn in HEK293 cells. Cell lysates of HEK293 cells co-transfected with S protein and α-Syn were prepared and used for Co-IP. The coimmunoprecipitates were analyzed by Western blotting with anti-α-Syn. (C) Interaction between endogenous SARS-CoV-2 N protein and α-Syn in HEK293 cells. Cell lysates of HEK293 cells co-transfected with N protein and α-Syn were prepared and used for Co-IP. The coimmunoprecipitates were analyzed by Western blotting with anti-α-Syn.
Figure 3
Figure 3
Elevated expression of α-Syn by SARS-CoV-2 proteins in HEK293 cells. (A) qRT-PCR analysis of the expression of α-Syn in HEK293 cells overexpressing S and N proteins. GAPDH was used as a loading control (n = 3). (B) Two days following transfection with pCMV3-S or pCMV3-N plasmids, the total protein from the HKE293 cells was extracted and detected by anti-SARS-CoV-2 S protein and anti-SARS-CoV-2 N protein. (C) Immunoblotting was performed using Syn1, an antibody that recognizes total α-Syn. GAPDH was used as a loading control. (D) The cells transfected with plasmids pCMV3-S or pCMV3-N for 48 h were fixed with paraformaldehyde containing 0.1% Triton X-100. Then, anti-α-Syn was detected by indirect immunofluorescence. DAPI was used to stain nuclei. (E) Western blotting detected “soluble” and “insoluble” fraction with an antibody against α-Syn (Syn1). p value represents results of One-way ANOVA. * p < 0.05; ** p < 0.01. “ns” means no significant difference.
Figure 4
Figure 4
The SARS-CoV-2 proteins cause Lewy-like pathology in HEK293 cells overexpressing α-Syn. (A) Seventy-two hours after HEK293 cells overexpressing α-Syn had been transfected with pCMV3-S or pCMV3-N plasmids, they were fixed and stained with anti-α-Syn aggregate (5G4). Expression of aggregated α-Syn was observed using fluorescence confocal microscopy. (B) Seventy-two hours after HEK293 cells overexpressing α-Syn had been transfected with pCMV3-S or pCMV3-N plasmids, the cells were fixed and stained with anti-pS129-α-Syn. The results were observed under fluorescence confocal microscopy. (C) The total protein from the HKE293 cells was extracted and detected by anti-pS129-α-Syn. The expression levels were assessed by ImageJ. * p < 0.05.

Similar articles

Cited by

References

    1. Shahid Z., Kalayanamitra R., McClafferty B., Kepko D., Ramgobin D., Patel R., Aggarwal C.S., Vunnam R., Sahu N., Bhatt D., et al. COVID-19 and Older Adults: What We Know. J. Am. Geriatr. Soc. 2020;68:926–929. doi: 10.1111/jgs.16472. - DOI - PMC - PubMed
    1. Rosen B., Kurtishi A., Vazquez-Jimenez G.R., Møller S.G. The Intersection of Parkinson’s Disease, Viral Infections, and COVID-19. Mol. Neurobiol. 2021;58:4477–4486. doi: 10.1007/s12035-021-02408-8. - DOI - PMC - PubMed
    1. Chaná-Cuevas P., Salles-Gándara P., Rojas-Fernandez A., Salinas-Rebolledo C., Milán-Solé A. The Potential Role of SARS-CoV-2 in the Pathogenesis of Parkinson’s Disease. Front. Neurol. 2020;11:1044. doi: 10.3389/fneur.2020.01044. - DOI - PMC - PubMed
    1. Sinha S., Mittal S., Roy R. Parkinson’s Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy. J. Mov. Disord. 2021;14:184–192. doi: 10.14802/jmd.21046. - DOI - PMC - PubMed
    1. Conte C. Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4. Int. J. Mol. Sci. 2021;22:7135. doi: 10.3390/ijms22137135. - DOI - PMC - PubMed